| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5581751 | Clinical Lymphoma Myeloma and Leukemia | 2016 | 11 Pages |
Abstract
Elderly patients aged < 75 years were able to tolerate standard immunochemotherapy, with acceptable survival profiles. In an Asian population, 75 years seems to be a judicious cutoff for predicting treatment outcomes.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Ja Min Byun, Jeong-Ok Lee, Beodeul Kang, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Soo-Mee Bang, Jong Seok Lee,